Immunoglobulin heavy chain switch region gene polymorphisms in glomerulonephritis. 1990

R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
Medical Unit, London Hospital Medical College.

Much evidence suggests that primary IgA nephropathy (IgAN) and idiopathic membranous nephropathy (MN) are immune complex mediated diseases. Moreover, genetic factors may play an important role in their pathogenesis. Recently, restriction fragment length polymorphisms (RFLPs) of the immunoglobulin heavy chain genes have been described which appear to associate with glomerulonephritis. We have studied RFLPs of the switch region of the IgM (S mu) and IgA1 (S alpha 1) heavy chain in MN and IgAN. DNA obtained from British Caucasoids with IgAN (N = 75), MN (N = 43), and normal controls (N = 73), was digested with the restriction enzyme Sac1, and studied using Southern blot techniques and hybridization with a 32P labelled DNA probe homologous to S mu. This probe detects RFLPs at the S mu and S alpha 1 loci. The genotypic and allelic frequencies of the S mu and S alpha 1 alleles in IgAN and MN was similar to normal controls. Caucasoid subjects with IgAN from Northern and Southern Europe (Finland and Italy, respectively) were also studied to determine whether an ethnic variation in genetic susceptibility to IgAN exists. The frequency of the S mu and S alpha 1 alleles was similar between the patient groups and their respective local healthy controls. These results do not support the recent findings of an association with RFLPs of the S mu and S alpha 1 loci in IgAN and MN, and suggest that the immunoglobulin heavy chain switch region genes are not important in conferring disease susceptibility to IgAN or MN.

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D007075 Immunoglobulin M A class of immunoglobulin bearing mu chains (IMMUNOGLOBULIN MU-CHAINS). IgM can fix COMPLEMENT. The name comes from its high molecular weight and originally was called a macroglobulin. Gamma Globulin, 19S,IgM,IgM Antibody,IgM1,IgM2,19S Gamma Globulin,Antibody, IgM
D007134 Immunoglobulin Switch Region A site located in the INTRONS at the 5' end of each constant region segment of a immunoglobulin heavy-chain gene where recombination (or rearrangement) occur during IMMUNOGLOBULIN CLASS SWITCHING. Ig switch regions are found on genes encoding all five classes (IMMUNOGLOBULIN ISOTYPES) of IMMUNOGLOBULIN HEAVY CHAINS. Ig Switch Region,Switch Region, Immunoglobulin,Heavy-Chain Mu Switch Region,Ig Switch Sequences,Ig Switch Regions,Ig Switch Sequence,Immunoglobulin Switch Regions,Region, Ig Switch,Region, Immunoglobulin Switch,Regions, Ig Switch,Regions, Immunoglobulin Switch,Sequence, Ig Switch,Sequences, Ig Switch,Switch Region, Ig,Switch Regions, Ig,Switch Regions, Immunoglobulin,Switch Sequence, Ig,Switch Sequences, Ig
D007558 Italy A country in southern Europe, a peninsula extending into the central Mediterranean Sea, northeast of Tunisia. The capital is Rome. Sardinia
D012150 Polymorphism, Restriction Fragment Length Variation occurring within a species in the presence or length of DNA fragment generated by a specific endonuclease at a specific site in the genome. Such variations are generated by mutations that create or abolish recognition sites for these enzymes or change the length of the fragment. RFLP,Restriction Fragment Length Polymorphism,RFLPs,Restriction Fragment Length Polymorphisms
D004739 England A part of Great Britain within the United Kingdom.
D005387 Finland A country in northern Europe, bordering the Baltic Sea, Gulf of Bothnia, and Gulf of Finland, between Sweden and Russia. The capital is Helsinki. Aland Islands,Ă…land Islands
D005922 Glomerulonephritis, IGA A chronic form of glomerulonephritis characterized by deposits of predominantly IMMUNOGLOBULIN A in the mesangial area (GLOMERULAR MESANGIUM). Deposits of COMPLEMENT C3 and IMMUNOGLOBULIN G are also often found. Clinical features may progress from asymptomatic HEMATURIA to END-STAGE KIDNEY DISEASE. Berger Disease,Immunoglobulin A Nephropathy,Nephropathy, IGA,Berger's Disease,IGA Glomerulonephritis,IGA Nephropathy,Iga Nephropathy 1,Nephritis, IGA Type,Bergers Disease,Glomerulonephritides, IGA,IGA Type Nephritis,Nephropathy 1, Iga,Nephropathy, Immunoglobulin A
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015139 Blotting, Southern A method (first developed by E.M. Southern) for detection of DNA that has been electrophoretically separated and immobilized by blotting on nitrocellulose or other type of paper or nylon membrane followed by hybridization with labeled NUCLEIC ACID PROBES. Southern Blotting,Blot, Southern,Southern Blot

Related Publications

R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
February 1988, The Journal of clinical investigation,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
September 1988, Diabetic medicine : a journal of the British Diabetic Association,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
November 1986, Clinical and experimental immunology,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
December 1992, Nihon rinsho. Japanese journal of clinical medicine,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
January 1989, International immunology,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
April 1995, Clinical nephrology,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
February 1997, Molecular immunology,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
January 1988, Immunogenetics,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
January 1981, Nature,
R H Moore, and G A Hitman, and R A Sinico, and J Mustonen, and J Medcraft, and E Y Lucas, and N T Richards, and M C Venning, and J Cunningham, and F P Marsh
April 1993, Journal of neuroimmunology,
Copied contents to your clipboard!